▶ 調査レポート

患者シミュレーターの世界市場:シミュレーションの種類別(マネキンベース、Webベース)、シミュレーションソフトウェアの種類別(パフォーマンス記録ソフトウェア、仮想チューター)、トレーニングサービス別、エンドユーザー別、地域別分析

• 英文タイトル:Global Patient Simulators Market - Segmented by Type of Simulation, Simulation Software, Training Service, End Users, and Geography - Growth, Trends & Forecasts (2018 - 2013)

Mordor Intelligenceが調査・発行した産業分析レポートです。患者シミュレーターの世界市場:シミュレーションの種類別(マネキンベース、Webベース)、シミュレーションソフトウェアの種類別(パフォーマンス記録ソフトウェア、仮想チューター)、トレーニングサービス別、エンドユーザー別、地域別分析 / Global Patient Simulators Market - Segmented by Type of Simulation, Simulation Software, Training Service, End Users, and Geography - Growth, Trends & Forecasts (2018 - 2013) / B-MOR-08441資料のイメージです。• レポートコード:B-MOR-08441
• 出版社/出版日:Mordor Intelligence / 2018年5月1日
• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User(1名様用)¥629,000 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥666,000 (USD4,500)▷ お問い合わせ
  Corporate User¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、患者シミュレーターの世界市場について調べ、患者シミュレーターの世界規模、市場動向、市場環境、シミュレーションの種類別(マネキンベース、Webベース)分析、シミュレーションソフトウェアの種類別(パフォーマンス記録ソフトウェア、仮想チューター)分析、トレーニングサービス別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・患者シミュレーターの世界市場インサイト
・患者シミュレーターの世界市場環境
・患者シミュレーターの世界市場動向
・患者シミュレーターの世界市場規模
・患者シミュレーターの世界市場規模:シミュレーションの種類別(マネキンベース、Webベース)
・患者シミュレーターの世界市場規模:シミュレーションソフトウェアの種類別(パフォーマンス記録ソフトウェア、仮想チューター)
・患者シミュレーターの世界市場規模:トレーニングサービス別
・患者シミュレーターの世界市場規模:エンドユーザー別
・患者シミュレーターの世界市場:地域別市場規模・分析
・患者シミュレーターの北米市場規模・予測
・患者シミュレーターのアメリカ市場規模・予測
・患者シミュレーターのヨーロッパ市場規模・予測
・患者シミュレーターのアジア市場規模・予測
・患者シミュレーターの日本市場規模・予測
・患者シミュレーターの中国市場規模・予測
・患者シミュレーターのインド市場規模・予測
・患者シミュレーターの韓国市場規模・予測
・関連企業情報・競争状況

The global patient simulators market is expected to grow at a CAGR of approximately 14% during the forecast period (2018-2023). North America held the largest share in 2017 and is expected to retain its leading position in the forecast period.

Increasing Healthcare Costs

According to research estimates, more resources are expected to be spent on health expenditure, with a projected 9% increase in GDP, across the world, allocated to health-spending, by 2040. But there will be substantial variation in the levels of health investments. Past trends and relationships suggest that low and lower-middle-income countries will spend the least on health, even when estimates include foreign aid from donor countries. High-income countries are expected to spend approximately USD10,000 per person on health in 2040, compared to the projected USD 2,000 for upper-middle income countries, USD 500 in lower-middle income countries, and USD 150 in low-income countries. This disparity in spending, indicates the huge demand for lowering healthcare costs and providing value-based services. Consequently, patient simulators market is expected to grow, as their increased use will directly contribute to lowering of the overall healthcare costs. Patient simulators are used to derive better patient outcomes, by means of simulation, thereby driving lower healthcare costs. Apart from these, factors like innovation in healthcare and technology, and an increasing focus on patient safety is driving the growth of global patient simulators market.

Lack of Funds for Research & Development

Despite the widespread use of patient simulators and medical simulators in general, the overall funding for the same at global scale is low. Medical simulators are extensively employed in medical academic institutions, hospitals, and defense organizations. Despite such extensive usage, there are few organized sources of funding for the development of simulators. The advancements in simulator technology and software is independently brought about by vendors in this space, with little contribution from government agencies. Consequently, the growth of the market is being limited, due to lack of funding for research and development of simulators. Additionally, factors like high cost of simulators, is also limiting the market growth.

Academic Institutions are the Leading End Users

The medical simulators did not gain popularity until the recent past, because of the high costs of medical simulators and a reluctance to adopt to the new training systems. This scenario, however, has changed and simulators have become relatively more reliable and function as aids to train medical personnel and medical students, in turn reducing the medical errors. Consequently, the major end users of the patient simulators market are academic institutions.

Key Developments in the Market

• January, 2018 – CAE Healthcare announced the release of CAE LucinaAR with Microsoft HoloLens, the world’s first augmented reality childbirth simulator with integrated mother-baby physiology.
• January, 2018 – Laerdal Medical announced that it will launch the new SimNewB® and SimBaby™ simulators at the International Meeting on Simulation in Healthcare (IMSH) conference in Los Angeles, CA.

Major Players – 3D SYSTEMS, CAEE INC., GAUMARD SCIENTIFIC COMPANY, KYOTO KAGAKU CO. LTD, LAERDAL MEDICAL AS, MEDTICE AB, SIMULAB CORPORATION, SIMULAIDS INC., AND SURGICAL SCIENCE SWEDEN

Reasons to Purchase this Report

• Current and future market outlook for patient simulators in the developed and emerging markets
• Analyze various perspectives on the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3 month analyst support, along with the market estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products And Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Healthcare Costs
6.1.2 Continous Innovation in Healthcare and Technology
6.1.3 Inreasing Focus on Patient Safety
6.2 Market Restraints
6.2.1 Lack of Funds for Research & Development
6.2.2 High Cost of Simulators
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type of Simulation
7.1.1 Mannequin-based Simulation
7.1.1.1 Patient Simulators
7.1.1.2 Surgical Simulators
7.1.1.3 Endovascular Simulators
7.1.1.4 Ultrasound Simulators
7.1.1.5 Dental Simulators
7.1.1.6 Eye Simulators
7.1.1.7 Task Trainers
7.1.2 Web-based Simulation
7.1.2.1 Second Life
7.1.2.2 Serious Games
7.2 By Type of Simulation Software
7.2.1 Performance Recording Software
7.2.2 Virtual Tutors
7.3 By Training Service
7.3.1 Vendor-based Training
7.3.2 Custom Consulting Services
7.3.3 Educational Societies
7.4 By End Users
7.4.1 Academic Institution
7.4.2 Hospitals
7.4.3 Military Organisations
7.5 By Geography
7.5.1 North America
7.5.1.1 US
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 UK
7.5.2.2 Germany
7.5.2.3 France
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 China
7.5.3.2 Japan
7.5.3.3 India
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of Asia-Pacific
7.5.4 Middle East & Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 3D Systems
9.2 CAE Inc.
9.3 Gaumard Scientific Company
9.4 Kyoto Kagaku Co. Ltd
9.5 Laerdal Medical AS
9.6 Medtice AB
9.7 Simulab Corporation
9.8 Simulaids Inc.
9.9 Surgical Science Sweden
*List is not Exhaustive
10. Future of the Market